Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

NeoRx announces license agreement with Angiotech

Nov. 11, 1998

Canadian team describes cardioprotective activity of AAA-135

Nov. 10, 1998

Eplerenone effectively treats hypertension and aldosterone-induced damage in CV organs

Nov. 9, 1998

NK-26588: new inhibitor of iNOS produced by Streptomyces sp.

Nov. 9, 1998

Further evidence of the potential utility of BO-653 in restenosis

Nov. 9, 1998

Novel endothelin antagonists claimed for cardiovascular, cerebrovascular and other disorders

Nov. 6, 1998

Ribozyme oligonucleotides against apo(a) as novel therapeutic strategy for cardiovascular diseases

Nov. 5, 1998

Merck's new ET receptor antagonists

Nov. 5, 1998

Optimal dosing regimen for 5G1.1-SC in heart attack under evaluation in phase I trial

Nov. 4, 1998

Involvement of central A3 receptors in blood pressure regulation

Nov. 3, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...